Molbio Diagnostics bulk deals and stake changes
NSE: MOLBIOBSE: 544866Healthcare Equipment & Supplies
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,259.70.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹14,279 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No balance sheet
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Aug 2026
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 13,05,45320.6% delivered
Molbio Diagnostics stake sales and purchases
All 4 disclosures on record.
Sep 2026
- SoldIndia Business Excellence Fund III, a scheme of Business Excellence Trust III2.06% of the company23,77,627 sharesholds 6.85% after30 Sep 2026 · filed under the 2% rule · Open Market
- SoldIndia Business Excellence Fund III2.60% of the company30,00,000 sharesholds 8.92% after23 Sep 2026 · filed under the 2% rule · Open Market
- SoldIndia Business Excellence Fund III, a scheme of Business Excellence Trust III2.60% of the company30,00,000 sharesholds 8.92% after23 Sep 2026 · filed under the 2% rule · Open Market
- SoldIndia Business Excellence Fund III, a scheme of Business Excellence Trust III2.60% of the company30,00,000 sharesholds 8.92% after23 Sep 2026 · filed under the 2% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Molbio Diagnostics bulk deals
Last 12 months, since 23 Oct 2025: 16 bulk deals, ₹1,406 Cr bought and ₹1,421 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Wednesday 30 Sep 20262 firms · ₹302 Cr bought · ₹306 Cr soldNet sold ₹3.82 Cr
- SoldBUSINESS EXCELLENCE TRUST IIISold 23,28,996 at ₹1,315.012.02% of the company₹306 Cr
- BoughtHDFC MUTUAL FUNDBought 23,00,000 at ₹1,315.002.00% of the company₹302 Cr
Wednesday 23 Sep 20262 firms · ₹362 Cr bought · ₹394 Cr soldNet sold ₹32 Cr
- SoldBUSINESS EXCELLENCE TRUST IIISold 29,96,798 at ₹1,315.002.60% of the company₹394 Cr
- BoughtKOTAK MAHINDRA MUTUAL FUNDBought 27,50,000 at ₹1,315.002.39% of the company₹362 Cr
Wednesday 16 Sep 20261 firm · ₹76 Cr bought · ₹76 Cr soldNet sold ₹0.17 Cr
- Both waysJUNOMONETA FINSOL PRIVATE LIMITEDBought 5,90,709 at ₹1,288.14Sold 5,91,823 at ₹1,288.600.51% of the companyNet −1,114 shares₹76 Cr bought
Friday 11 Sep 20264 firms · ₹608 Cr bought · ₹586 Cr soldNet bought ₹22 Cr
- Both waysHRTI PRIVATE LIMITEDBought 7,37,245 at ₹1,520.67Sold 6,01,018 at ₹1,547.450.64% of the companyNet +1,36,227 shares₹112 Cr bought
- Both waysQE SECURITIES LLPBought 12,10,738 at ₹1,542.36Sold 11,88,458 at ₹1,552.021.05% of the companyNet +22,280 shares₹187 Cr bought
- Both waysJUNOMONETA FINSOL PRIVATE LIMITEDBought 12,33,175 at ₹1,565.79Sold 12,28,332 at ₹1,566.941.07% of the companyNet +4,843 shares₹193 Cr bought
- Both waysMICROCURVES TRADING PRIVATE LIMITEDBought 7,53,493 at ₹1,544.97Sold 7,53,493 at ₹1,545.880.65% of the companyNet nil₹116 Cr bought
Monday 17 Aug 20261 firm · ₹57 Cr bought · ₹57 Cr soldNet sold ₹0.03 Cr
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 5,79,903 at ₹990.82Sold 5,79,903 at ₹991.34Net nil₹57 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 16 deals on record since listing on 17 Aug 2026.